Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00625625 | Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | unknown | Phase 2 | 225 | Saint John's Cancer InstituteOTHER | 0 | Sep 17, 2013 | clinicaltrials |
| NCT01110785 | Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 46 | Leiden University Medical CenterOTHER | 1 | Sep 17, 2013 |
| NCT01586117 | A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00974389 | S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | unknown | Phase 2 | 40 | Osaka Medical CollegeOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01097265 | Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery | unknown | Phase 2 / Phase 3 | 1,500 | Jeroen Bosch ZiekenhuisOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01190462 | Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 51 | Leiden University Medical CenterOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01899118 | Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01839539 | Study of DC-CIK to Treat Colorectal Cancer | unknown | Phase 2 | 60 | Guangxi Medical UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01832948 | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01763450 | Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01237665 | IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer(IXOr) | unknown | Phase 2 | 15 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01384994 | Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients | unknown | Phase 2 | 111 | PD Dr. med. Volker HeinemannOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT00931840 | A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma | unknown | Phase 2 | 220 | Enzon Pharmaceuticals, Inc.INDUSTRY | 5 | Sep 20, 2011 | clinicaltrials |
| NCT00438737 | Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 2, 2011 | clinicaltrials |
| NCT01322178 | Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients(CLIME) | unknown | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT01056796 | Compression Anastomosis For Low Anterior Resection in Previously Radiated Patients Using the CAR™ 27 | unknown | Phase 2 | 10 | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 47 | Hopital Jean MinjozOTHER | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00594529 | Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers | unknown | Phase 2 | 27 | Kyoto UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00635466 | Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal Carcinoma(Lap RC) | unknown | Phase 2 | 495 | Japan Society of Laparoscopic Colorectal SurgeryNETWORK | 1 | Jun 16, 2011 | clinicaltrials |
| NCT00006112 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | unknown | Phase 2 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT01340508 | Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Apr 22, 2011 | clinicaltrials |
| NCT01305980 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 4, 2011 | clinicaltrials |
| NCT01157806 | Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases | unknown | Phase 2 | 20 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT00784667 | Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib(Dux) | unknown | Phase 2 | 50 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249521 | Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer(Vengeance) | unknown | Phase 2 | 40 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00172159 | Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers | unknown | Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2010 | clinicaltrials |
| NCT01142713 | The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study | unknown | Phase 2 | 30 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 / Phase 3 | 600 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer(EXPERT-C) | unknown | Phase 2 | 164 | Royal Marsden NHS Foundation TrustOTHER | 3 | Jan 13, 2010 | clinicaltrials |
| NCT00997685 | Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC) | unknown | Phase 2 | 110 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00853684 | Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer(OXCE) | unknown | Phase 2 | 44 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00972465 | Study of Nimotuzumab to Treat Colorectal Cancer | unknown | Phase 2 | 48 | Peking UniversityOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00964457 | Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00496704 | Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan | unknown | Phase 1 / Phase 2 | 56 | Yonsei UniversityOTHER | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00513266 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | unknown | Phase 2 | 35 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | unknown | Phase 2 | 206 | Institut Cancerologie de l'OuestOTHER | 1 | Jul 8, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2013source: clinicaltrials